healthcare
healthcare Articles
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most...
Published:
Last Updated:
The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were increased.
Published:
Last Updated:
Microsoft announced that it is working with Providence St. Joseph Health, a U.S. hospital chain, in an effort to build a new high-tech hospital.
Published:
Last Updated:
Sangamo Therapeutics made a handy gain to start out the week after the firm, in conjunction with Pfizer, announced updated results from a mid-stage trial evaluating a treatment for hemophilia.
Published:
Last Updated:
Intra-Cellular Therapies has announced top-line results from its two late-stage trial in patients with bipolar depression.
Published:
Last Updated:
Merrill Lynch has coverage on the marijuana industry, and when a major Wall Street firm like this one starts and maintains coverage, it pretty much legitimizes things for good.
Published:
Last Updated:
Canopy Growth shares dipped on Wednesday after the company announced that its co-CEO will step down, leaving just one man in the driver’s seat.
Published:
Last Updated:
24/7 Wall St. has picked a few of those standouts from Tuesday to highlight. We have included information about each company, as well as recent trading activity and the consensus analyst price target.
Published:
Last Updated:
Pfizer shares were up slightly on Monday after the firm announced topline results from its most recent late-stage study in young children with mild to moderate atopic dermatitis, also known as eczema.
Published:
Last Updated:
Pfizer released initial clinical data from its Phase 1b gene therapy study for Duchenne muscular dystrophy. While these results did not necessarily live up to expectations, there is a winner in this.
Published:
Last Updated:
Health Catalyst, a leading provider of data and analytics technology and services to health care organizations, has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
Rite Aid shares soared after it reported its most recent quarterly results and on news of a partnership with Amazon.
Published:
Last Updated:
Adaptive Biotechnologies entered the market with a bang on Thursday, well above the high end of the expected price range.
Published:
Last Updated:
Walgreens released better-than-expected fiscal third-quarter financial results before the markets opened on Thursday.
Published:
Last Updated:
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Published:
Last Updated: